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Pro-B1X: The Creator of Bone 
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AIM 1. Determine the role of Pro-B1X in homeostatic conditions 
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Wild-type mice were injected daily for two weeks with PBS, a Scrambled peptide or 
Pro-B1X, tibias were isolated and analysed via micro-CT for percentage of bone 
volume vs trabecular volume.  
Data are means +/- SE, PBS n=5, Scrambled n=9, Pro-B1X n=11, analysed by two-way 
ANOVA, *<0.05 
CIA was initiated in WT mice. Upon first signs of inflammation, mice were daily 
injected with PBS, Scrambled control, or Pro-B1X for 2 weeks, after which the 
experiment was terminated.  
Hind limbs were inspected for bone erosion, sectioned and TRAP stained in order to 
count osteoclasts. Data are means +/- SE, analysed by two-way ANOVA, *<0.05 
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Figure 1. Pro-B1X increases trabecular parameters in vivo 
Pro-B1X 
We have identified a novel peptide, Pro-B1X, which may also have a role in 
strengthening bone in normal conditions and decreasing bone damage during 
inflammatory diseases such as RA. 
AIM 2. Identify the therapeutic potential of Pro-B1X during 
inflammatory bone damage 
References: 
1. Thayer MK, 2018 Jun 1;9:2151459318776101. 
Figure 2. Pro-B1X has therapeutic potential during CIA model 
Inflammatory diseases 
(e.g. rheumatoid 
arthritis (RA)) have a lot 
of bone damage, 
reducing quality of life. 
Current treatments for bone damage are only able to slow down the 
bone damage and can not restore bone to its healthy state.  
 
Hip fractures affect ~2% of 
women over 65 hip every 
year!1  
 
There are no effective 
treatments to prevent this. 
 
Micro-CT images of trabecular bone from control mice and mice injected with Pro-
B1X 
Representative images of hind paws from PBS and Pro-B1X injected mice following 
micro-CT scanning. 
A: Collagen II/CFA 
injection 
administered 
D: Arthritis develops within one 
week of booster. 
At first sign of inflammation – begin 
daily I.P injections of treatment for 
14 days 
E: End of study – 24 
hours post 14th I.P 
injection 
C: Booster of 
Collagen II/IFA 
injection 
administered 
B: Scoring 
begins 
Bone homeostasis 
Wild-type mice were injected 
daily with Pro-B1X, Scrambled 
control or PBS for 2 weeks.  
Collagen-induced arthritis (CIA) 
Wild-type mice were injected 
daily with Pro-B1X, Scrambled 
control or PBS for 2 weeks.  
Osteoclast staining 
Sections were stained for Tartate-
resistant acid phosphatase (TRAP) 
and osteoclasts were counted 
 
 
 
 
Micro-CT 
Limbs were micro-CT scanned 
and analysed for trabecular bone 
 
 
 
 
Methods 
